Most popular features of 2014 from The Pharmaceutical Journal Using visual representations of data to tell a story is proving popular, with infographic features taking first, second and third place in the top five features of 2014.…
Top 10 learning articles of 2014 from The Pharmaceutical Journal Our response to the Ebola outbreak is a sign of how our learning content is changing to meet your needs.…
Top 10 news stories of 2014 from The Pharmaceutical Journal Harriet Adcock provides a rundown of the top ten news stories of 2014.…
Safinamide recommended for approval as Parkinson’s disease therapy A new medicine that allows Parkinson’s disease patients to spend more of the day symptom-free has been recommended for approval in Europe.…
Diuretic therapy explained The different mechanisms of action that classes of diuretic have means they can be used to treat a variety of conditions.…
Risk of heart problems prompts removal of OTC diclofenac from UK pharmacy shelves Oral diclofenac tablets, used for short-term pain relief, will no longer be available as an over-the-counter pharmacy medicine in the UK.…
Dulaglutide launched in the UK as once-weekly diabetes treatmentThe second once-weekly non-insulin injection for patients with type 2 diabetes became available in the UK from 13 January 2015.…
Increased risk of severe skin reactions with expectorants containing ambroxol or bromhexinePatients taking expectorants containing ambroxol or bromhexine have a small increased risk of severe skin reactions such as Stevens-Johnson syndrome.…
Learn about dosage form design ‘Design and manufacture of pharmaceutical tablets’, by Reynir Eyjolfsson.…
FDA plays catch-up with Europe as it moves towards first biosimilar approval The US Food and Drug Administration (FDA)’s oncologic drugs advisory committee has given the green light to Sandoz’s EP2006, a biosimilar version of filgrastim.…